Richter Gedeon’s headquarters in Budapest
Richter BioLogics GmbH & CoKG, the microbial biologics affiliate of Richter Gedeon, inaugurated a new state-of-the-art biotechnology plant in Bovenau, northern Germany, on September 13. The capacity expansion is one of the largest investments the Hungarian company has made in the last decade, writes the Richter’s portal.
“The commissioning of this facility is an important milestone in the implementation of Richter BioLogics’ growth strategy. With one of the largest investments for Richter in the last decade, we have become a key player in meeting global market demand and supplying the global pharmaceutical industry with the highest quality biotechnology products. We are also increasing our flexibility, one of our greatest and most valuable strengths,” emphasized Dr. Kai Pohlmeyer, Managing Director of Richter BioLogics.
The facility is equipped with the latest state-of-the-art technology for the clinical and large-scale production and market supply of protein- and plasmid DNA-based active pharmaceutical ingredients.
The total area of the multi-purpose …